All filters
Slidesets
Penetration of rifampin and rifapentine into diseased lung in the rabbit cavity pulmonary disease model of TB - D. Rifat
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Clofazimine: Current Status and Future Prospects - Eric Nuermberger, MD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Population pharmacokinetics and penetration of first and second line anti-TB drugs in pulmonary lesions from adults with active tuberculosis - S. Gupta
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
04_Denti
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
The Pharmacokinetics/Pharmacodynamics of Delamanid - Suresh Mallikaarjun, PhD, FCP
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Pharmacokinetics and pharmacodynamics of pyrazinoic acid in murine models of tuberculosis - J. Lanoix
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Pharmacodynamics of sulfamethoxazole in in vitro and in vivo models of tuberculosis - E. Nuermberger
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Contribution of different oxazolidinones to the efficacy of novel regimens containing bedaquiline and pretomanid in murine models of tuberculosis - R. Tasneen
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Pharmacokinetics of rifampicin and moxifloxacin in the PanACEA-MAMS-TB-01 trial - R. Aarnoutse
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
The Systems Pharmacology Approach to Improve TB Treatment - Rada Savic, PharmD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Concentration-response effects of combination therapy in a murine model of tuberculosis: optimizing the dosing regimen for short-course therapy - N. Zhang
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
12_Wiltshire
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Dose optimization for combinations of three or more drugs: an application to dose selection in regimen-based tuberculosis drug development - M. Lyons
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Mathematical model of drug-target binding predicts optimal antibiotic treatment - P. Abel zur Wiesch
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
TB and Diabetes Mellitus: Pharmacological Aspects of the Convergence of Two Epidemics - Rovina Ruslami, MD, PhD
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Digitizing MTB Medicines: Using compounding methods to enable mobile capture of MTB medication adherence - S. Browne
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Prediction of drug partitioning into tubercular pulmonary lesions - C. Chen
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Drug Partitioning and Local Microenvironmental Conditions affect Bedaquiline, Clofazimine and Pyrazinamide Treatment Responses in Mycobacterium tuberculosis Infected C3HeB/FeJ Mice - S. Irwin
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015
Slidesets
Quantitative modeling of time to positivity following dosing of bedaquiline and rifafour in patients with pulmonary tuberculosis infection - J.F. Marier
Presented at:
International Workshop on Clinical Pharmacology of Tuberculosis Drugs 2015